Vector Science and Therapeutics Corp. has seen a notable uptick in its stock price this week, continuing its impressive performance year-to-date.
Vector Science and Therapeutics Corp. (PAIN.V) has had a positive week, with its stock price increasing by 7.14%. This follows a year marked by a substantial gain of 271.13%. As of the latest close, the stock is trading at C$1.89, reflecting the company's ongoing developments and investor interest.
Advertisement
Vector Science and Therapeutics Corp.
PAIN.V
PAIN.V
Vector Science and Therapeutics Corp.
WealthAwesomeMarket cap
$281.46M
52W high
$2.65
52W low
$0.35
1W change
+7.14%
Beta
4.67
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on PAIN's historical volatility
30-Day Vol
99.5%
Annualized
90-Day Vol
101.9%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$1.51
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$1.70 | C$1.20 – C$2.39 |
| 60 trading days | C$1.60 | C$0.98 – C$2.60 |
| 90 trading days | C$1.51 | C$0.83 – C$2.73 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: While Vector Science and Therapeutics Corp. has demonstrated strong performance metrics this year, potential investors should consider the volatility indicated by its beta and the lack of profitability as reflected in its financials.
Vector Science and Therapeutics Corp. has surged 271.13% YTD.
With a current market cap of approximately C$281.5 million and a beta of 4.67, the stock exhibits high volatility, making it a risky investment for conservative investors.
Bull case
The significant year-to-date gain shows strong market interest and potential growth opportunities in the biotech sector. This could benefit Vector Science and Therapeutics as it continues to develop its product pipeline.
Bear case
Despite recent gains, the company's negative profit margin and return on equity raise concerns about its financial stability and long-term viability, especially in a competitive industry.
Price Action Overview
Advertisement
Vector Science and Therapeutics Corp. (PAIN.V) has experienced a notable 7.14% increase in its stock price this week, closing at C$1.89. This follows a strong year-to-date performance, reflecting a remarkable gain of 271.13%. The stock has also seen a monthly decline of 1.64%, indicating some fluctuations in the short term.
Technical Picture
The technical indicators for PAIN.V suggest a generally positive outlook. The stock is currently above its 50-day moving average of C$1.85, indicating a bullish trend, and well above its 200-day moving average of C$1.72, which points to long-term strength. The 52-week range has been between C$0.35 and C$2.65, with the current price sitting at 67% of this range. The stock's beta of 4.67 indicates significant volatility, which may appeal to risk-tolerant investors. However, the recent trading volume of 88,571 shares is notably lower than the 20-day average of 163,713 shares, reflecting potential caution among traders.
Fundamental Insights
Vector Science and Therapeutics Corp. currently holds a market cap of approximately C$281.5 million. However, the company is grappling with a profit margin of 0.0% and a return on equity of -104.1%, which raises concerns regarding its profitability and financial health. The earnings per share (EPS) stands at -0.02, further emphasizing the challenges the company faces in achieving sustainable profitability.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
